Protein-protein interactions (PPIs) can be considered as a vast class of therapeutic targets. PPIs play critical roles in all biological functions and are often dysregulated in disease. Despite their functional role both inside and outside the cell, over the past decades PPIs have been neglected as undruggable targets. This was in part due to the fact that PPI interfaces are generally flat and large (roughly 1,000-2,000 Å 2 per side), in contrast to the cavities that typically accommodate small molecules (around 300-500 Å 2 ). Another challenge is that unlike enzymes or G protein-coupled receptors there is no endogenous ligands or substrates to start the drug design process. Starting around the years 2000 and up to now, a clinically approved integrin antagonist (tirofiban) and other numerous investigations suggest a hopeful emerging view: small drug-like molecules can modulate PPIs. Mutational analysis of protein interfaces revealed that just some amino acids present at the interfaces were directly responsible for the protein-protein complex stabilization which are defined as hotspot residues. Hotspots tend to be located as clusters around the center of the interface on both protein partners that is often called hot region. Small molecules that interact with these hotspot residues can inhibit protein-protein interactions which kwon as orthosteric inhibitions.
formation of functional IN tetramer. The divergent resistance pathway of these inhibitors in comparison with active site integrase inhibitors and their multimodal mode of actions make them candidates for future HIV-drug discovery.In summary, recent advances in proteomics, computational chemistry, and ligand design have made PPIs from undruggable to attractive targets for the development of therapeutics. Today, nearly a dozen PPIs inhibitors have been in the clinic. Overall, the future of PPI seems bright and much progress in this area has generated the courage to move forward, even with enthusiasm. 
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